Back

prof. dr. M.C. (Monique) Minnema

Full Professor

  • Department of Medical Oncology

prof. dr. M.C. (Monique) Minnema

Biography

Prof Dr Monique Minnema was trained as internist and hematologist at Academic Medical Center, Amsterdam and the University Medical Center, Utrecht. She started working as a hematologist in 2005 at the department of hematology, UMC Utrecht and specialized in the diagnosis and treatment of B cell malignancies, especially plasma cell dyscrasis  like Multiple Myeloma and AL amyloidosis, and Waldenstrom Macroglobulinemia.
She is the medical head of the hematology research team which supervises more
than 20 clinical studies. Her main focus of clinical research is the
development of novel therapies (both cellular and drug) developments for plasma
cell dyscrasias and she was appointed full professor of hematology in 2019.

Prof Dr Minnema is an active member of the HOVON working parties for Multiple
Myeloma, Lymphoma and the vice president of the Lunenburg Lymphoma consortium (LLPC) for phase I/II studies. Examples of her work are the HOVON 104 trial for
patients with AL amyloidosis first line treatment and the clinical studies with
the monoclonal antibody Daratumumab in relapsed Multiple Myeloma and anti CD19 CAR T cells in relapsed Lymphoma. Her translational research focuses on the immunotherapy for multiple myeloma, bone remodeling after successful anti myeloma treatment and the possibilities of personalized cancer treatment in this bone marrow cancer. She was a member of the organizing committee of the Waldenström workshop in Amsterdam in 2016.

Research Output (125)

EBV-related lymphoma after long-term daratumumab treatment:a case report

Verpoorte-Botden Ilse P G, Minnema Monique C, Raymakers Reinier A P 1 nov 2020, In: Blood cancer journal. 10 , p. 113

Consensus treatment recommendations from the tenth International Workshop for Waldenström Macroglobulinaemia

Castillo Jorge J, Advani Ranjana H, Branagan Andrew R, Buske Christian, Dimopoulos Meletios A, D'Sa Shirley, Kersten Marie José, Leblond Veronique, Minnema Monique C, Owen Roger G, Palomba M Lia, Talaulikar Dipti, Tedeschi Alessandra, Trotman Judith, Varettoni Marzia, Vos Josephine M, Treon Steven P, Kastritis Efstathios nov 2020, In: Lancet haematology. 7 , p. e827-e837

Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic

Talaulikar Dipti, Advani Ranjana H, Branagan Andrew R, Buske Christian, Dimopoulos Meletios A, D'Sa Shirley, Kersten Maria J, Leblond Veronique, Minnema Monique C, Owen Roger G, Palomba Maria Lia, Tedeschi Alessandra, Trotman Judith, Varettoni Marzia, Vos Josephine M, Treon Steven P, Kastritis Efstathios, Castillo Jorge J aug 2020, In: HemaSphere. 4 4 p.

Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma:8 vs 4 Induction Cycles; the Carthadex Trial

Wester Ruth, Zweegman Sonja, van der Holt Bronno, Kersten Marie José, Vellenga Edo, van Marwijk-Kooy Marinus, Asselbergs Emelie, de Weerdt Okke, Minnema Monique C, Lonergan Sarah, Palumbo Antonio, Broijl Annemiek, Sonneveld Pieter aug 2020, In: HemaSphere. 4 3 p.

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia:The ASPEN study

Tam Constantine S, Opat Stephen, D'Sa Shirley, Jurczak Wojciech, Lee Hui-Peng, Cull Gavin, Owen Roger G, Marlton Paula, Wahlin Björn Engelbrekt, Garcia-Sanz Ramon, McCarthy Helen, Mulligan Stephen, Tedeschi Alessandra, Castillo Jorge, Czyz Jaroslaw, Fernández de Larrea Carlos, Belada David, Libby Edward, Matous Jeffrey V, Motta Marina, Siddiqi Tanya, Tani Monica, Trneny Marek, Minnema Monique C, Buske Christian, Leblond Veronique, Chan Wai Y, Schneider Jingjing Yan, Ro Sunhee, Cohen Aileen, Huang Jane, Dimopoulos Meletios A 30 jul 2020, In: Blood. 136 , p. 2038-2050 13 p.

Challenges in the Management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic

Kastritis Efstathios, Wechalekar Ashutosh, Schönland Stefan, Sanchorawala Vaishali, Merlini Giampaolo, Palladini Giovanni, Minnema Monique, Roussel Murielle, Jaccard Arnaud, Hegenbart Ute, Kumar Shaji, Cibeira Maria Teresa, Blade Joan, Dimopoulos Meletios A 1 jun 2020, In: British Journal of Haematology. 190 , p. 346-357 12 p.

A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide

Gamberi Barbara, Berthou Christian, Hernandez Miguel, Semenzato Gianpietro, Tholouli Eleni, Hájek Roman, Caers Jo, Dimopoulos Meletios, Minnema Monique C, Andreasson Bjorn, Parreira Joana, Crotty Gerard, Remes Kari, Kueenburg Elisabeth, Rosettani Barbara, Di Micco Antonia, Peters Sarah, Bacon Pamela, Blau Igor Wolfgang 13 mei 2020, In: Clinical Lymphoma, Myeloma and Leukemia. 20 , p. e629-e644

Daratumumab Plus CyBorD for Patients With Newly Diagnosed AL Amyloidosis:Safety Run-in Results of ANDROMEDA

Palladini Giovanni, Kastritis Efstathios, Maurer Mathew S, Zonder Jeffrey A, Minnema Monique C, Wechalekar Ashutosh D, Jaccard Arnaud, Lee Hans C, Bumma Naresh, Kaufman Jonathan L, Medvedova Eva, Kovacsovics Tibor J, Rosenzweig Michael A, Sanchorawala Vaishali, Qin Xiang, Vasey Sandra Y, Weiss B, Vermeulen Jessica, Merlini Giampaolo, Comenzo Raymond L 3 apr 2020, In: Blood. 136 , p. 71-80 10 p.

Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial

Doorduijn Jeanette K, Zijlstra Josee M, Lugtenburg Pieternella J, Kersten Marie Josee, Böhmer Lara H, Minnema Monique C, MacKenzie Marius A, van Marwijk Kooij Rien, de Jongh Eva, Snijders Tjeerd J F, de Weerdt Okke, van Gelder Michel, Hoogendoorn Mels, Leys Rineke B L, Kibbelaar Robby E, de Jong Daphne, Chitu Dana A, Van't Veer Mars B, Kluin-Nelemans Hanneke C 9 mrt 2020, In: British Journal of Haematology. 190 , p. 385-393 9 p.

Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL)

Topp Max S., van Meerten Tom, Houot Roch, Minnema Monique, Milpied Noel, Lugtenburg Pieternella J., Thieblemont Catherine, Wermke Martin, Song Kevin, Avivi Irit, Kuruvilla John, Duehrsen Ulrich, Chu Rachel, Zheng Lianqing, Plaks Vicki, Kerber Anne, Kersten Marie Jose mrt 2020, In: Biology of Blood and Marrow Transplantation. 26 , p. S101-S101

All Research Output (125)